Minimal Cerebrospinal Fluid Concentration of Miltefosine despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis. [PDF]
Monogue ML +6 more
europepmc +1 more source
Application of Histone Deacetylase Inhibitors MPK472 and KSK64 as a Potential Treatment Option for Acanthamoeba Keratitis. [PDF]
Lee HA +6 more
europepmc +1 more source
Unnecessary antibiotic prescribing in pediatric ambulatory care visits for bronchitis and bronchiolitis in the United States, 2006-2015. [PDF]
Snyder RL +3 more
europepmc +1 more source
Nitroxoline evidence amoebicidal activity against Acanthamoeba castellanii through DNA damage and the stress response pathways. [PDF]
Chen L +5 more
europepmc +1 more source
<i>Mentha rotundifolia</i>, a Source of Amoebicidal Agents Against <i>Naegleria fowleri</i>. [PDF]
Ben Youssef M +9 more
europepmc +1 more source
In Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria and Pathogen Boxes To Discover Novel Compounds with Activity against Balamuthia mandrillaris. [PDF]
Rice CA +3 more
europepmc +1 more source
Implementation of real-time PCR assays for diagnosing intestinal protozoa infections. [PDF]
Lotz CN +5 more
europepmc +1 more source
Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications. [PDF]
Baig AM.
europepmc +1 more source
The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis. [PDF]
Bao M, Bao H, Wang S, Zhou H.
europepmc +1 more source
Acanthamoeba Keratitis Management and Prognostic Factors: A Systematic Review. [PDF]
Marques-Couto P +4 more
europepmc +1 more source

